Eventi SITeCS

Detection and treatment of dyslipidaemias

Cinisello Balsamo (MI), 29-30 November 2023

[continua a leggere]

Present and Future Approaches to the Control of Dyslipidaemias

Virtual Edition, from Dec 22, 2020
[continua a leggere]


LDL e malattie cardiovascolari: dalle linee guida alla terapia

[continua a leggere]

Il controllo del colesterolo LDL: presente e futuro

[continua a leggere]


Per essere informati sulle novità di SITeCS iscrivetevi alla nostra newsletter inserendo il vostro indirizzo di posta elettronica

Area Soci

Eventi SITeCS

Bookmark and Share

Lipid, Lipoproteins and Hypolipidaemic Therapy



Lipid, Lipoproteins and Hypolipidaemic Therapy
Cinisello B.mo (MI), 18-19 June 2015







In recent years, with regard to the lipid-lowering therapy, therapy with statins has been validated and a series of novel therapeutic approaches has been developed.
If, on the one hand, the pivotal role of statin therapy is confirmed by a large series of studies, the role of the reduction of LDL cholesterol has also been confirmed, as the clinical benefit appears to be independent of the method with which LDL are decreased. Objectives of this course are:
1) to conduct a review of what is known and established in the primary and secondary prevention of cardiovascular disease through the use of lipid-lowering therapy, and indicate possible areas of differentiation between the major therapeutic classes and within them;
2) to conduct a survey on new therapeutic approaches, both for rare diseases of lipid metabolism that for the population in general;
3) indicate new emerging causal factors that may be of interest in clinical practice.





JUNE, 18

13.30-14.00 Introduction to the course - Alberico L. Catapano
14.00-14.30 TG rich lipoproteins, emerging roles in atherosclerosis - Danilo Norata
14.30-14.45 Discussion
14.45-15.30 HDL: quantity or quality?- John Chapman
15.30-15.45 Discussion

Coffee Break

16.00-18.30 Clinical rounds: group split with case discussion - Lluís Masana

Visit to the Lipid Clinic - Liliana Grigore, Fabio Pellegatta

JUNE, 19

09.00-09.30 Guidelines: shall we revise after the IMPROVE IT? - Alberico L.Catapano
09.30-09.45 Discussion
09.45-10.05 Lipid Lowering therapy, the current status - Lluís Masana
10.05-10.15 Discussion

Coffee Break

10.30-11.00 Current evidence with statins, effects beyond LDL chol - Alberto Corsini
11.00-11.15 Discussion
11.15-11.45 The EAS consensus on statin intolerance - Alberto Corsini
11.45-12.00 Discussion
12.00-12.30 Future lipid lowering therapies: what is new? - Alberico L.Catapano
12.30-13.00 Discussion and close of the meeting

13.15 Lunch and Departures




Alberico Luigi Catapano
Department of Pharmacological and Biomolecular Sciences
University of Milan.

John Chapman
Research Professor
Medical Faculty of the Pierre and Marie Curie University, (UPMC), Paris.

Alberto Corsini
Department of Pharmacological and Biomolecular Sciences
University of Milan.

Liliana Grigore
SISA Atherosclerosis Center, Bassini Hospital - Cinisello B.mo (MI).

Lluís Masana Marín
Internal Medicine Department and Lipid and Cardiovascular Risk Unit
University Hospital Sant Joan - Reus - Spain.

Giuseppe Danilo Norata
Department of Pharmacological and Biomolecular Sciences
University of Milan.

Fabio Pellegatta
SISA Atherosclerosis Center, Bassini Hospital - Cinisello B.mo (MI).



Scientific secretariat
SITeCS- Societa ltaliana di Terapia Clinica e Sperimentale via Balzaretti, 7- 20133 Milano
tel: +39 02 49636373 - fax: +39 02 49633384
e-mail: segreteria@sitecs.it